<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35856065</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2666-6022</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>American heart journal plus : cardiology research and practice</Title><ISOAbbreviation>Am Heart J Plus</ISOAbbreviation></Journal><ArticleTitle>Characteristics of patients referred to a cardiovascular disease clinic for post-acute sequelae of SARS-CoV-2 infection.</ArticleTitle><Pagination><StartPage>100176</StartPage><MedlinePgn>100176</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100176</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ahjo.2022.100176</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">There is limited literature on cardiovascular manifestations of post-acute sequelae of SARS-CoV-2 infection (PASC).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This observational study aimed to describe the characteristics, diagnostic evaluations, and new cardiac diagnoses in patients referred to a cardiovascular disease clinic designed for patients with PASC, and to identify factors associated with cardiovascular symptoms with no identifiable cardiac pathology.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Of 126 patients, average age was 46&#xa0;years, and 34&#xa0;% were male. Patients presented on average five months after COVID-19 diagnosis. The most common symptoms were dyspnea (52&#xa0;%), chest pain/pressure (48&#xa0;%), palpitations (44&#xa0;%), and fatigue (42&#xa0;%), commonly associated with exertion or exercise intolerance. New cardiovascular diseases were present in 23&#xa0;% of cases. The remainder exhibited common symptoms which we termed "cardiovascular PASC syndrome."</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">We found that only one in four patients had a new cardiovascular diagnosis, but most displayed a pattern of symptoms associated with exercise intolerance.</AbstractText><CopyrightInformation>&#xa9; 2022 Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Stephen Y</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adejumo</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>See</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onuma</LastName><ForeName>Oyere K</ForeName><Initials>OK</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Edward J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spatz</LastName><ForeName>Erica S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation, New Haven, CT, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 MD010711</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007205</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 EB028106</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM136651</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am Heart J Plus</MedlineTA><NlmUniqueID>101779333</NlmUniqueID><ISSNLinking>2666-6022</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiovascular diseases</Keyword><Keyword MajorTopicYN="N">Coronavirus disease 2019</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of COVID-19</Keyword></KeywordList><CoiStatement>Dr Spatz reports that she receives research funding from the Centers for Disease Control and Prevention (ClinicalTrials.gov Identifier: NCT04610515) to study the long-term health outcomes of COVID in adults. She served on an expert panel on Long Covid, hosted by Regeneron. Dr Spatz receives funding from the National Institute on Minority Health and Health Disparities, the U.S. Food and Drug Administration to support projects within the Yale-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI), and from the National Heart, Lung, and Blood Institute. Other authors: no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>20</Day><Hour>4</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35856065</ArticleId><ArticleId IdType="pmc">PMC9277988</ArticleId><ArticleId IdType="doi">10.1016/j.ahjo.2022.100176</ArticleId><ArticleId IdType="pii">S2666-6022(22)00093-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27(4):601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutchmansingh D.D., Knauert M.P., Antin-Ozerkis D.E., et al. A clinic blueprint for post-coronavirus disease 2019 RECOVERY: learning from the past, looking to the future. Chest. 2021;159(3):949&#x2013;958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7641526</ArticleId><ArticleId IdType="pubmed">33159907</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical Spectrum of SARS-CoV-2 Infection. 2021. https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/</Citation></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Group ftGAC-P-ACS. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Estiri H., Strasser Z.H., Brat G.A., Semenov Y.R., Patel C.J., Murphy S.N. Evolving phenotypes of non-hospitalized patients that indicate long COVID. BMC Med. 2021;19(1):249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8474909</ArticleId><ArticleId IdType="pubmed">34565368</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul B.D., Lemle M.D., Komaroff A.L., Snyder S.H. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc. Natl. Acad. Sci. U. S. A. 2021;118(34)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans P.C., Rainger G.E., Mason J.C., et al. Endothelial dysfunction in COVID-19: a position paper of the ESC working Group for Atherosclerosis and Vascular Biology, and the ESC Council of basic cardiovascular science. Cardiovasc. Res. 2020;116(14):2177&#x2013;2184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454368</ArticleId><ArticleId IdType="pubmed">32750108</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine B.D., Zuckerman J.H., Pawelczyk J.A. Cardiac atrophy after bed-rest deconditioning: a nonneural mechanism for orthostatic intolerance. Circulation. 1997;96(2):517&#x2013;525.</Citation><ArticleIdList><ArticleId IdType="pubmed">9244220</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I., Joseph P., Heerdt P.M., et al. Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest. 2021;161(1):54&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph P., Arevalo C., Oliveira R.K.F., et al. Insights from invasive cardiopulmonary exercise testing of patients with myalgic Encephalomyelitis/Chronic fatigue syndrome. Chest. 2021;160(2):642&#x2013;651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727854</ArticleId><ArticleId IdType="pubmed">33577778</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryarly M., Phillips L.T., Fu Q., Vernino S., Levine B.D. Postural orthostatic tachycardia syndrome: JACC focus seminar. J. Am. Coll. Cardiol. 2019;73(10):1207&#x2013;1228.</Citation><ArticleIdList><ArticleId IdType="pubmed">30871704</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>